Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 19 Lung Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Ovarian Neoplasms 2 Uterine Cervical Neoplasms 1 Stomach Neoplasms 1 Squamous-Cell Lung Cancer 1 Small Cell Lung Carcinoma 1 Retinoblastoma 1 Retinal Neoplasms 1 Resectable Lung Non-Small Cell Carcinoma 1 Recurrence 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Ovarian Cancer Recurrent 1 Oropharyngeal Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 NSCLC 1 Head and Neck Neoplasms 1 Fallopian Tube Neoplasms 1 Esophageal Neoplasms 1 Carcinoma, Bronchogenic 1 Bronchial Neoplasms 1 Advanced Non Small Cell Lung Cancer 1 Adenocarcinoma of Lung 1

Interventions

Cisplatin 32 Radiotherapy, Intensity-Modulated 17 Radiotherapy 17 Carboplatin 14 Radiation 11 Magnetic Resonance Spectroscopy 10 Cetuximab 8 Specimen Handling 7 Platinum 7 Paclitaxel 7 1,2-diaminocyclohexaneplatinum II citrate 7 Docetaxel 6 Chemoradiotherapy 6 Surgical Procedures, Operative 5 pembrolizumab 4 Nivolumab 4 Celecoxib 4 cemiplimab 3 Taxes 3 Surveys and Questionnaires 3 Fluorouracil 3 Drug Therapy 3 toripalimab 2 durvalumab 2 aldesleukin 2 X-Rays 2 Standard of Care 2 Restraint, Physical 2 Observation 2 Neck Dissection 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Oropharyngeal Neoplasms × Platinum Compounds × Clear all

NCT06234748 2026-05-18

ARTHOUSE

University of Michigan Rogel Cancer Center

Phase 2 Active not recruiting

Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡